NR2F2 Regulates Cell Proliferation and Immunomodulation in Whartons’ Jelly Stem Cells
(1) Background: Wharton’s Jelly stem cells (WJ-MSCs) are multipotent mesenchymal stem cells that can proliferate rapidly and have low immunogenicity. Therefore, WJ-MSCs have gained considerable attention in the fields of immunomodulation and disease treatment and have entered clinical trials for the...
Main Authors: | Li Ma, Min Huang, Xiaohua Liao, Xiyu Cai, Qiang Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/13/8/1458 |
Similar Items
-
The Molecular Regulatory Mechanism in Multipotency and Differentiation of Wharton’s Jelly Stem Cells
by: Li Ma, et al.
Published: (2023-08-01) -
Wharton’s Jelly Mesenchymal Stem Cells: Differentiation Capacity Showing its Role in Bone Tissue Engineering
by: Rizal Rizal, et al.
Published: (2020-11-01) -
Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton’s jelly mesenchymal stromal cells
by: Mathiyazhagan Rengasamy, et al.
Published: (2017-06-01) -
Possible Underlying Mechanisms for the Renoprotective Effect of Retinoic Acid-Pretreated Wharton’s Jelly Mesenchymal Stem Cells against Renal Ischemia/Reperfusion Injury
by: Mai Barakat, et al.
Published: (2022-06-01) -
Wharton’s jelly mesenchymal stem cells: a concise review of their secretome and prospective clinical applications
by: Hana Drobiova, et al.
Published: (2023-06-01)